SCHEMBL12066434

SCHEMBL12066434

COC(=O)N[C@@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(C#Cc3ccc(-c4cnc([C@@H]5CCCN5)[nH]4)cc3)cc2)[nH]1)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.57
CYP2C9 P11712 3/20 0.57
KCNH2 Q12809 3/20 0.57
NR1I2 O75469 2/20 0.57
ABCB11 O95342 1/20 0.57
OPRK1 P41145 1/20 0.57
CYP1A2 P05177 2/20 0.52
CYP2D6 P10635 1/20 0.52
PRCP P42785 5/20 0.43
OPRM1 P35372 1/20 0.42
OPRD1 P41143 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13747597 0.95 CYP3A4 (0.63) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL10145003 0.93 CYP3A4 (0.65) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL12069123 0.92 KCNH2 (0.50) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL27989787 0.92 CYP3A4 (0.56) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL10177241 0.91 CYP3A4 (0.56) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL10177242 0.91 CYP3A4 (0.56) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL10253814 0.91 CYP3A4 (0.57) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL691890 0.91 CYP3A4 (0.57) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL691891 0.91 CYP3A4 (0.57) CYP3A4CYP2C9KCNH2NR1I2ABCB11
SCHEMBL692828 0.91 CYP3A4 (0.57) CYP3A4CYP2C9KCNH2NR1I2ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011150243-A1 INHIBITORS OF HCV NS5A PRESIDIO PHARMACEUTICALS, INC. (US) 2011-12-01 WO disclosed
WO-2010065668-A1 INHIBITORS OF HCV NS5A PRESIDIO PHARMACEUTICALS, INC. (US) 2010-06-10 WO disclosed